SELLAS LIFE SCIENCES GROUP, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 16th, 2021 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 16th, 2021 Company Industry JurisdictionSELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: